Jefferies Group LLC United Therapeutics Corp Transaction History

Jefferies Group LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $250,005 - $298,683	-1,390 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$170.47 - $211.93 $1.24 Million - $1.55 Million	-7,291 Reduced 83.99%	1,390 $249,000
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.24 Million - $1.55 Million	-7,291 Reduced 83.99%	1,390 $249,000
Q1 2021 Sep 21, 2023	SELL	$153.94 - $174.85 $612,065 - $695,203	-3,976 Reduced 31.41%	8,681 $1.45 Million
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $612,065 - $695,203	-3,976 Reduced 31.41%	8,681 $1.45 Million
Q4 2020 Sep 21, 2023	BUY	$101.87 - $151.79 $1.29 Million - $1.92 Million	12,657 New	12,657 $1.92 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $1.01 Million - $1.5 Million	9,910 Added 360.76%	12,657 $1.92 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $987,929 - $1.44 Million	-12,444 Reduced 81.92%	2,747 $260,000
Q4 2019 Feb 13, 2020	BUY	$78.31 - $95.34 $1.19 Million - $1.45 Million	15,191 New	15,191 $1.34 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $848,312 - $1.08 Million	-8,366 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $1.23 Million - $1.4 Million	-10,851 Reduced 56.47%	8,366 $1.07 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $1.74 Million - $2.04 Million	17,236 Added 870.07%	19,217 $2.17 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $3.9 Million - $5.52 Million	-36,351 Reduced 94.83%	1,981 $223,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $4.55 Million - $5.8 Million	38,332	38,332 $5.67 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.